During the past decade, CHUM-Notre-Dame, Pharmacie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CHUM-Notre-Dame, Pharmacie
According to Clinical.Site data, the most researched conditions in "CHUM-Notre-Dame, Pharmacie" are
"Huntington's Disease" (2 trials). Many other conditions were trialed in "CHUM-Notre-Dame, Pharmacie" in a lesser frequency.
Clinical Trials Intervention Types at CHUM-Notre-Dame, Pharmacie
Most popular intervention types in "CHUM-Notre-Dame, Pharmacie" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "20 mg BID of PF-02545920" (1 trials), "PF-02545920" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHUM-Notre-Dame, Pharmacie
The vast majority of trials in "CHUM-Notre-Dame, Pharmacie" are
2 trials for "All" genders.
Clinical Trials Status at CHUM-Notre-Dame, Pharmacie
Currently, there are NaN active trials in "CHUM-Notre-Dame, Pharmacie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CHUM-Notre-Dame, Pharmacie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CHUM-Notre-Dame, Pharmacie, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".